首页> 美国卫生研究院文献>other >Pharmacokinetics and Pharmacodynamics of Oral Testosterone Enanthate Plus Dutasteride for 4 Weeks in Normal Men: Implications for Male Hormonal Contraception
【2h】

Pharmacokinetics and Pharmacodynamics of Oral Testosterone Enanthate Plus Dutasteride for 4 Weeks in Normal Men: Implications for Male Hormonal Contraception

机译:正常男性口服睾丸激素庚酸酯加度他雄胺4周的药代动力学和药效学:对男性荷尔蒙避孕的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral administration of testosterone enanthate (TE) and dutasteride increases serum testosterone and might be useful for male hormonal contraception. To ascertain the contraceptive potential of oral TE and dutasteride by determining the degree of gonadotropin suppression mediated by 4 weeks of oral TE plus dutasteride, 20 healthy young men were randomly assigned to 4 weeks of either 400 mg oral TE twice daily or 800 mg oral TE once daily in a double-blinded, controlled fashion at a single site. All men received 0.5 mg dutasteride daily. Blood for measurement of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, dihydrotesterone (DHT), and estradiol was obtained prior to treatment, weekly during treatment, and 1, 2, 4, 8, 12, 13, 14, 16, 20, and 24 hours after the morning dose on the last day of treatment. FSH was significantly suppressed throughout treatment with 800 mg TE once daily and after 4 weeks of treatment with 400 mg TE twice daily. LH was significantly suppressed after 2 weeks of treatment with 800 mg TE, but not with 400 mg TE. Serum DHT was suppressed and serum estradiol increased during treatment in both groups. High-density lipoprotein cholesterol was suppresed during treatment, but liver function tests, hematocrit, creatinine, mood, and sexual function were unaffected. The administration of 800 mg oral TE daily combined with dutasteride for 28 days significantly suppresses gonadotropins without untoward side effects and might have utility as part of a male hormonal contraceptive regimen.
机译:口服施用庚酸酯(TE)和度他雄胺可增加血清睾丸激素水平,可能对男性荷尔蒙避孕有用。为了确定口服TE和度他雄胺的避孕潜力,方法是确定口服TE和度他雄胺4周介导的促性腺激素抑制程度,将20名健康的年轻男性随机分为4周,每天两次400 mg口服TE或800 mg口服TE每天在一个站点上以双盲,受控方式进行一次。所有男性每天接受0.5 mg度他雄胺。在治疗前,治疗期间每周一次以及1、2、4、8、12、13时获得用于测定血清黄体生成激素(LH),促卵泡激素(FSH),睾丸激素,二氢睾丸激素(DHT)和雌二醇的血液。在治疗的最后一天早晨服药后的第14、16、16、20和24小时。在每天一次800 mg TE的治疗过程中和每天两次400 mg TE的治疗4周后,FSH均被显着抑制。用800 mg TE治疗2周后LH被显着抑制,但未使用400 mg TE治疗。两组治疗期间血清DHT均被抑制,血清雌二醇增加。在治疗期间,高密度脂蛋白胆固醇被认为是无效的,但肝功能检查,血细胞比容,肌酐,情绪和性功能均未受影响。每天800 mg口服TE与度他雄胺联用28天,可显着抑制促性腺激素,而无不良副作用,并且可作为男性荷尔蒙避孕方案的一部分使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号